ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CARE GA Receives Study May Proceed Letter from US FDA to Initiate Phase II Clinical Trial of Senhwa's Silmitasertib in COVID-19 Patients
November 09, 2020Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, announced its clinical partner- Center for Advanced Research and Education (CARE) in ...
Pharma Sources Insight January 2025
